NasdaqGS:ILMNLife Sciences
Is It Time To Reassess Illumina (ILMN) After Its Sharp One Year Share Price Rebound
Wondering if Illumina at US$126.74 is offering value or just noise after a big rebound? This breakdown will help you frame that question clearly.
The stock has returned 1.0% over the last 7 days and 2.8% over the last 30 days, while year to date it is down 5.7% but up 65.7% over the past year, with 3 year and 5 year returns of 33.6% and 65.4% declines respectively.
These moves come against a backdrop of ongoing attention on gene sequencing, regulatory developments, competition in genomics...